Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Edward Kogan

Clinical Cardiac Electrophysiology West Orange, NJ Medical Doctor

NPI 1528591179 CMS profile 11253881

375 Mount Pleasant Ave Ste 102, West Orange, NJ 07052

Open in the dashboard

General payments

$23,888

254 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Edward Kogan of West Orange, NJ is reported in the CMS Open Payments database as having received $23,888 across 254 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 56th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,332 94
2024 General $10,258 76
2023 General $9,397 60
2022 General $394 11
2021 General $507 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edward Kogan
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Edward Kogan were reported at $3,332. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Edward Kogan Clinical Cardiac Electrophysiology median Middle half National median
2019 $0 $2,361 $585–$8,260 $163
2020 $0 $993 $247–$4,351 $114
2021 $507 $1,185 $326–$4,739 $132
2022 $394 $2,073 $554–$6,789 $149
2023 $9,397 $2,568 $759–$8,159 $160
2024 $10,258 $2,557 $703–$7,403 $164
2025 $3,332 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $13,120 123 payments
  2. Biotronik Inc. $5,091 52 payments
  3. Medtronic, Inc. $3,591 22 payments
  4. Boston Scientific Corporation $911 23 payments
  5. Biosense Webster, Inc. $298 4 payments
  6. Amgen Inc. $269 8 payments
  7. Chiesi USA, Inc. $191 6 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $181 5 payments
  9. AstraZeneca Pharmaceuticals LP $115 5 payments
  10. Pfizer Inc. $27 2 payments
  11. Other $95 4 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Grant $12,500 5 payments
  2. Food and Beverage $8,882 238 payments
  3. Travel and Lodging $1,521 5 payments
  4. Education $963 5 payments
  5. Entertainment $22 1 payment
Products named General payments · program years 2021–2025
  1. TACTICATH ABLATION CATHETER, SENSOR ENABLED $2,610 10 payments
  2. TACTICATH $2,500 1 payment
  3. BIOMONITOR $1,422 14 payments
  4. Acticor 7 VR-T DX $1,058 4 payments
  5. Solia $835 3 payments
  6. Plexa ProMRI $808 2 payments
  7. Sentus $808 2 payments
  8. Edora 8 DR-T $808 2 payments
  9. AVEIR $649 15 payments
  10. ENSITE $587 19 payments
  11. Other $4,713 156 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

29

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$81

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

0%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cephalexin Generic 29 $81

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Records

254 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record